Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference23 articles.
1. Steensma DP, Bennett JM . The myelodysplastic syndromes: diagnosis and treatment. Mayo Clin Proc 2006; 81: 104–130.
2. Aul C, Arnin M, Runde V, Schneider W . Serum erythropoietin concentrations in patients with myelodysplastic syndromes. Leukemia Res 1991; 15: 571–575.
3. Clavio M, Balleari B, Garrone A, Ballerina F, Varaldo R, Michelis GL et al. Haematopoietic growth factors in myelodysplastic syndromes: toward patient-oriented therapy? J Exp Clin Cancer Res 2005; 24: 5–16.
4. Jädersten M, Montgomery SM, Dybedal I, Porwit-MacDonald A, Hellström-Lindberg E . Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF. Blood 2005; 106: 803–811.
5. Stasi R, Abruzzese E, Lanzetta G, Terzoli E, Amadori S . Darbepoetin alfa for the treatment of anemic patients with low- and intermediate-1-risk myelodysplastic syndromes. Ann Oncol 2005; 16: 1921–1927.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献